This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique, Université Joseph Fourier. Active years: 2003-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 645 
2 out of 5,383 
1 out of 112 Years Active: 2003-2008
Title: Jean Lhomme: A Pioneer in Biological Molecule Detection
Introduction
Jean Lhomme is a notable inventor based in Meylan, France, recognized for his significant contributions to the field of molecular biology. With a total of four patents to his name, Lhomme has focused his research on innovative reagents and methods that enhance the detection of biological molecules, particularly in the diagnostic arena.
Latest Patents
Lhomme's latest inventions include groundbreaking techniques such as a temperature-stable labeling reagent, which carries the diazomethyl functional group. This invention not only describes the formulation of the labeling reagent but also details methods for synthesizing these markers. The primary application of this innovation lies in the labeling of biological molecules, especially nucleic acids, which holds tremendous potential for diagnostics.
Another notable patent pertains to a method for fragmenting and labeling DNA. This technique involves creating abasic sites on single- or double-stranded deoxyribonucleic acid (DNA) and subsequently attaching a marker to the fragments using a labeling reagent. The reagent is designed to covalently bond to at least one phosphate of the fragment, offering promising applications within the field of diagnosis.
Career Highlights
Throughout his career, Jean Lhomme has worked for prestigious institutions, including Biomerieux, Inc. and the Centre National De La Recherche Scientifique. His work at these organizations has substantially contributed to advancements in medical diagnostics and molecular biology.
Collaborations
Lhomme has collaborated with distinguished colleagues, including Emmanuelle Trevisiol and Ali Laayoun. These collaborations have fostered an environment of innovation and shared knowledge, driving the development of new methodologies in the detection of biological molecules.
Conclusion
In conclusion, Jean Lhomme stands out as a key figure in the realm of innovation related to biological molecule detection. His patents and collaborative efforts have the potential to transform diagnostic practices, making significant strides toward enhanced healthcare solutions. As technology advances, Lhomme’s contributions will undoubtedly continue to play a pivotal role in the future of molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile